Earnings Ahead

ABT - Abbott

109.95 -1.12 -1.01

Abbott

Abbott

About

Profile

We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 103,000 of us are working to


Headquarters

Chicago, Illinois, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ABT



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Abbott posts 12% revenue drop amid baby formula disruption, waning COVID impact
  • Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.10, revenue of $10.1B beats by $410M
  • Abbott Q4 results in focus as DOJ probe on baby formula plant looms
  • Abbott under DOJ criminal probe over behavior at Michigan baby formula plant - WSJ
  • Catalyst watch: Tesla reverberations, Intel earnings, Rocket Lab launch and Macau stocks on holiday
  • Abbott receives FDA approval for transcatheter aortic valve implantation system
  • COVID-19 public health emergency extended by HHS, possibly for final time
  • WHO sets Jan. 27 meeting to decide on COVID emergency
  • CES 2023: What's happening at the Consumer Electronics Show?
  • Wynn Resorts and Merck among Wells Fargo's conviction calls for Q1
  • Diabetes rates in children set to skyrocket by 2060 - study
  • Imported baby formula to face US tariffs again in 2023 - WSJ
  • Goldman Sachs highlights key healthcare themes for 2023
  • Abbott wins FDA approval of Eterna spinal cord stimulation system
  • White House restarts program to ship free at-home COVID tests
  • WHO chief hopeful COVID emergency will end next year
  • Abbott Laboratories raises quarterly dividend by 8.5% to $0.51/share
  • EU wants to delay medical device law amid supply challenges - Reuters
  • Reckitt thinks U.S. baby formula shortage will persist until spring – Reuters
  • World Health Organization renames monkeypox as mpox